NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
156 hedge funds and large institutions have $2.79B invested in NEVRO CORP. in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 58 reducing their positions, and 21 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
27% more capital invested
Capital invested by funds: $2.19B → $2.79B (+$600M)
2% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 58
4% less funds holding
Funds holding: 162 → 156 (-6)
24% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 21
68% less call options, than puts
Call options by funds: $14.5M | Put options by funds: $44.8M
Top Buyers
| 1 |
FAM
Fred Alger Management
New York
|
+$64.8M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$48.5M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$28.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$24.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$24.6M |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$43.4M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$32.9M |
| 3 |
BC
Broadfin Capital
New York
|
-$25.6M |
| 4 |
DM
Deerfield Management
New York
|
-$25M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$24.6M |
NVRO Hedge Fund Activity: Q3 2019 in Review
156 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2019, worth a combined $2.79B — up 27% from $2.19B a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of NVRO and 16 opened new positions — a net loss of 5 holders — while 58 trimmed existing stakes and 57 added.
The largest buyer was Fred Alger Management, adding an estimated $64.8M. The largest seller was Franklin Resources, cutting an estimated $43.4M.
- 156 institutional investors held NEVRO CORP. (NVRO) as of Q3 2019, down from 162 in Q2 2019.
- Funds reported $2.79B of NEVRO CORP. stock for Q3 2019, up 27% quarter-over-quarter.
- 16 funds opened new NEVRO CORP. positions in Q3 2019 and 21 closed out, a net change of -5 holders.
- The largest NEVRO CORP. buyer in Q3 2019 was Fred Alger Management, an estimated $64.8M added.
- The largest NEVRO CORP. seller in Q3 2019 was Franklin Resources, an estimated $43.4M sold.
Based on aggregated 13F filings for Q3 2019.